Clinical characteristics related to methotrexate-induced pancytopenia

Clin Rheumatol. 1997 May;16(3):321-3. doi: 10.1007/BF02238974.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Incidence
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Middle Aged
  • Monitoring, Physiologic
  • Pancytopenia / chemically induced*
  • Pancytopenia / epidemiology
  • Risk Factors

Substances

  • Antirheumatic Agents
  • Methotrexate